Introduction
Hematological malignancies represent 10% of cancers in adults. Recent advances in diagnostic procedures and treatments including SCT have significantly improved survival and quality of life of most patients. Optimal diagnosis and treatment of patients, however, represent a real challenge for caregivers in countries with limited resources. Besides the cost of treatment, understaffed teams and the demands of patients regarding not only medical care but also social support had a great impact.
Context of care
Morocco is a country of 30 million inhabitants. The per capita income is $1200 and the minimum wage $180. The annual per capita medical expenditure is $50. Life expectancy is 71 years. Morocco faces problems typical of developing countries. In all, 19% of the population is below the poverty line and up to 50% is illiterate. Health-care insurance covered, until recently, only 15% of the population. This coverage has been expanding to 30 to 40%. Health care is free or requires a small financial contribution from patients.
Casablanca is the main city of the country. With more than 4 million inhabitants, it is the most populated city in North Africa and the fourth biggest in Africa. More than 60% of the economic activity of Morocco is concentrated in it.
The first hematological department (SHOP) was set up in Casablanca in 1980. Adult patients with hematological diseases and children with hematological diseases and various cancers are treated in this department. In 1982, a unit of pediatric hematology and oncology opened in the Children's Hospital in Rabat. In 1996, another unit of pediatric hematology and oncology was set up in the Children's Hospital of Casablanca. Up to now, SHOP is still the only specialized public facility where adult patients with hematological diseases can be treated. Some patients are treated in private clinics, mainly in Casablanca and Rabat.
Medical teams initiated collaboration with some hospitals and groups in Europe or the United States and set up nongovernment organizations (NGOs) with the main objective of collecting donations to help patients.
Organization of care and role of NGOs
A population-based registry has recently been set up in Casablanca. The data have, however, not been published so far. The data available are generated from hospital registries. It is estimated that 30 000-40 000 cancer cases should be diagnosed each year. However, only 10 000-12 000 patients were registered at cancer centers in Casablanca and Rabat. In our department, 1800-2000 new cases are admitted each year. This includes patients with various hematological diseases, including hereditary and benign diseases, and 400-500 children (Table 1) . Almost 90% of patients have no health-care coverage. The treatment of patients improved gradually in terms of toxic deaths, CR and survival. The main results are presented in Tables 2 and 3. The hospital, on the other hand, has very limited resources and cannot provide the very expensive treatment for this kind of diseases. The doctors understand that they cannot improve the quality of care without extra help. The NGOs played a crucial role in the improvement of care of these patients. The most active ones are Agir (support of patients with hematological diseases and children with cancer in Casablanca), Avenir (support of children with hematological diseases and children with cancer in Rabat) and AMINO (support of National Cancer Centre in Rabat). These associations proved to be very efficient and accompanied the hospital teams in their endeavor to provide better care. Their actions included renovation of the wards, purchasing medication and supplies, hiring staff and providing housing for patients. In Casablanca, Agir set up the first SCT ward in the country.
More recently, ALSLCC (Association Lalla Salma de Lutte Contre le Cancer) led by the Princess Lalla Salma has dramatically changed the context of care. This association has been able, in a short period of time, to find resources for improving the care of cancer patients including educational programs for caregivers, construction of houses for patients and parents, developing a program for improving prevention, and early diagnosis and advocacy for development of new cancer centers throughout the country.
The NGOs also played an important role in developing successful cooperative programs with hospitals and groups in Europe and the United States. The cooperation with St Jude Children Research Hospital (Memphis, TN, USA) has helped the teams to improve the nurses' care, developed an infection control program and data management, and provided training for physicians in various specialties. The French African Group of Pediatric Oncology (GFAOP) has also been very active in developing adapted treatment regimen in children. With Max Foundation, many needy patients can be administered Glivec for CML or GIST. Also, with the Bone Marrow Transplantation Centre in Pesaro (Italy), several patients could receive this treatment. 
